Keyword: Johnson & Johnson

Pfizer has joined three Big Pharma peers in a DOJ probe over allegations the companies paid bribes to a terrorist-run Iraqi health ministry.

After testing local market TV last year, Boston Scientific has expanded its TV media run for its Watchman heart implant device.

J&J has to face Pfizer's claims that it struck "anticompetitive" payer deals designed to freeze out Remicade biosimilars.

Lenvima's quarterly sales grow to $106 million; China makes 48-drug list for streamlined review; Samsung commits further investment in biologics.

Healthcare reporters questioned a Johnson & Johnson TV ad for anticoagulant treatment Xarelto, calling out potentially "misleading" visuals.

Trump reportedly told reporters before the dinner that he would make an announcement next week that would bring down drug prices “really substantially.”

Initial lab work suggests that the Ebola Zaire strain—the one targeted by Merck's rVSV-ZEBOV—is likely the cause of this outbreak.

Multinational pharma companies have all together closed 16 manufacturing plants in South Korea over the past 20 years, local media reports.

Pfizer was also cited in a lawsuit alleging U.S. companies funded terrorism by bribing Iraqi officials.

The Justice Department is eyeing claims that AstraZeneca bribed Iraqi health officials to win contracts even after Shiite terrorists took over.